Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kimia Biosciences has informed that it enclosed the details regarding the proceedings of the Extra-Ordinary General Meeting of the Company held on Tuesday, July 22nd , 2025 at 04:00 pm (IST) through Video Conferencing and other Audio Visual Means (VC/OAVM) in compliance with all the applicable provisions of Companies Act, 2013 and the rules made thereunder, the Securities Exchange Board of India (SEBI) (Listing Obligations and Disclosures Requirements) Regulations 2015 and the relevant circulars issued by Ministry of Corporate Affairs (MCA) and SEBI. In this regard, it has enclosed the summary of the proceedings of the Extra-Ordinary General Meeting (EGM) pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 read with circulars issued thereunder as Annexure-I. The above information will also be made available on the Company’s website at www.kimiabiosciences.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: